Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Hennessee

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Open Forum Infectious Diseases|November 20, 2025
Coccidioidomycosis-Associated Hospitalizations, United States, 2016-2021Samantha L Williams, Kaitlin Benedict, Ian Hennessee, et al.
Mycoses|September 4, 2025
New Asthma Diagnosis Codes or Short-Acting β<sub>2</sub> Agonist Prescriptions After Histoplasmosis Among Patients With Commercial Health Insurance, United States, 2018-2023Ian Hennessee, Kaitlin Benedict, Dallas J Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2025
Impact of fluconazole on outcomes of patients with primary pulmonary coccidioidomycosis: a commercial health insurance claims-based, propensity score matched analysisKaitlin Benedict, Ian Hennessee, Dallas J Smith, et al.
American Journal of Public Health|April 13, 2022
Hennessee et al. RespondIan Hennessee, Julie A Clennon, Lance A Waller, et al.
American Journal of Public Health|December 8, 2021
Considerations for Improving Reporting and Analysis of Date-Based COVID-19 Surveillance Data by Public Health AgenciesIan Hennessee, Julie A Clennon, Lance A Waller, et al.
Journal of the American Academy of Dermatology|April 30, 2024
Low incidence of invasive fungal infection and risk factors in a large observational cohort of patients initiating tumor necrosis factor-alpha inhibitors for dermatologic conditionsIan Hennessee, Kaitlin Benedict, Nathan C Bahr, et al.
Open Forum Infectious Diseases|August 28, 2025
Impact of Delays in Diagnosis on Healthcare Costs Associated With Blastomycosis, Coccidioidomycosis, and Histoplasmosis in a Commercially Insured PopulationKaitlin Benedict, Jason Massey, Michelle Fearon Scales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2024
Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid ArthritisIan Hennessee, Kaitlin Benedict, Nathan C Bahr, et al.
Journal of Fungi (Basel, Switzerland)|September 27, 2023
Blastomycosis-Associated Hospitalizations, United States, 2010-2020Kaitlin Benedict, Ian Hennessee, Jeremy A W Gold, et al.
Tropical Medicine & International Health : TM & IH|July 15, 2015
Reduction in symptomatic malaria prevalence through proactive community treatment in rural SenegalAnnē M Linn, Youssoupha Ndiaye, Ian Hennessee, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|November 20, 2025
Coccidioidomycosis-Associated Hospitalizations, United States, 2016-2021Samantha L Williams, Kaitlin Benedict, Ian Hennessee, et al.
Mycoses|September 4, 2025
New Asthma Diagnosis Codes or Short-Acting β<sub>2</sub> Agonist Prescriptions After Histoplasmosis Among Patients With Commercial Health Insurance, United States, 2018-2023Ian Hennessee, Kaitlin Benedict, Dallas J Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2025
Impact of fluconazole on outcomes of patients with primary pulmonary coccidioidomycosis: a commercial health insurance claims-based, propensity score matched analysisKaitlin Benedict, Ian Hennessee, Dallas J Smith, et al.
American Journal of Public Health|April 13, 2022
Hennessee et al. RespondIan Hennessee, Julie A Clennon, Lance A Waller, et al.
American Journal of Public Health|December 8, 2021
Considerations for Improving Reporting and Analysis of Date-Based COVID-19 Surveillance Data by Public Health AgenciesIan Hennessee, Julie A Clennon, Lance A Waller, et al.
Journal of the American Academy of Dermatology|April 30, 2024
Low incidence of invasive fungal infection and risk factors in a large observational cohort of patients initiating tumor necrosis factor-alpha inhibitors for dermatologic conditionsIan Hennessee, Kaitlin Benedict, Nathan C Bahr, et al.
Open Forum Infectious Diseases|August 28, 2025
Impact of Delays in Diagnosis on Healthcare Costs Associated With Blastomycosis, Coccidioidomycosis, and Histoplasmosis in a Commercially Insured PopulationKaitlin Benedict, Jason Massey, Michelle Fearon Scales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2024
Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid ArthritisIan Hennessee, Kaitlin Benedict, Nathan C Bahr, et al.
Journal of Fungi (Basel, Switzerland)|September 27, 2023
Blastomycosis-Associated Hospitalizations, United States, 2010-2020Kaitlin Benedict, Ian Hennessee, Jeremy A W Gold, et al.
Tropical Medicine & International Health : TM & IH|July 15, 2015
Reduction in symptomatic malaria prevalence through proactive community treatment in rural SenegalAnnē M Linn, Youssoupha Ndiaye, Ian Hennessee, et al.
Pageof 4